Apollo installs first automated microbial identification system in India

Published: 17-Dec-2012
Infection Control Analysis

MALDI-TOF-VITEK MS rapidly identifies disease-causing micro-organisms


Apollo Hospitals Group in New Delhi, India has installed the first bioMerieux MALDI-TOF-VITEK MS system in India. This automated microbial identification system detects disease-causing micro-organisms such as bacteria and fungi so that correct diagnosis and early treatment is achieved.

Dr Raman Sardana, senior consultant (Microbiology) and additional director, Medical Services at Apollo Hospitals Group, said: “Over the past decade, new technologies and automated solutions have greatly reduced the amount of time it takes to provide doctors with actionable results in managing infection. The rapid identification of micro-organisms has been shown to help guide patient treatment and improve clinical outcomes. Waiting several days for a definitive identification of the pathogen provides an obstacle to the clinician seeking to target therapy with the most effective treatment. This is where technologies such as MALDI-TOF-VITEK MS are helpful with their accuracy and specificity.”

The rapid identification of micro-organisms has been shown to help guide patient treatment and improve clinical outcomes

With the help of MALDI-TOF-VITEK MS, the type of infection or infections present can be speedily determined, allowing doctors more specifically to target their therapies with the right antimicrobial at the right dosage. This plays an important role in preventing and slowing the emergence of resistant bacteria and fungi. In the coming months identification of all microbes including virus could be a possibility.

MALDI-TOF-VITEK MS is based on matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS), which is said to be one of the latest and most promising technologies, producing results in a few minutes rather than days, as currently happens.

Apollo Hospitals Group is one of Asia's largest integrated healthcare organisations with more than 8,500 beds across 50 hospitals, more than 1,350 pharmacies and in excess of 100 diagnostic clinics. The Group also offers medical business process outsourcing services, health insurance services and clinical research divisions with a focus on epidemiological studies, stem cell research and genetic research.

  • Companies:
  • bioMerieux
See more

You may also like

Regulatory

UPDATE: US Pharmacopeia makes comments public on endotoxin testing overhaul

Read more
The USP has published the comments the organisation received in response to the addition of non-animal derived endotoxin testing methods, as well as an FAQ page on the issue

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Integrity testing of HEPA filters: A practical approach Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit for purpose once installed in your facility
  2. Microbiological monitoring: Adapting to new rapid methods regulatory demands Dr Wan Li Low from Cherwell takes a look at the shift towards Rapid Microbiology Methods (RMM) and their validation
  3. Syntegon launches new "Settle Plate Changer" for automated viable monitoring Syntegon has patented its new Settle Plate Changer (SPC) for automated viable monitoring in the aseptic filling process
  4. A guide to choosing the best particle sample point location Particle counting in pharmaceutical applications can be clearly segregated into one of three categories: certification, qualification and monitoring. Each category requires a different approach as explained by PMS' Mark Hallworth
  5. Endotoxin control in depyrogenation tunnels Understanding the way glassware is depyrogenated and how high concentrations of endotoxin can be used to assess how well depyrogenation tunnels are functioning is key to quality control. Tim Sandle explains

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

UPDATE: US Pharmacopeia makes comments public on endotoxin testing overhaul

The USP has published the comments the organisation received in response to the addition of non-animal derived endotoxin testing methods, as well as an FAQ page on the issue
Analysis

bioMérieux and JMI partner to fight antimicrobial resistance

The two firms have announced a six year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR
Cleaning

bioMérieux launches assay for simultaneous Salmonella and Listeria detection

France-based bioMérieux has introduced GENE-UP ENVIROPRO that simultaneously detects both Salmonella and Listeria through a single enriched sample with PCR confirmation
Manufacturing

Recombinant Factor C assay to aid demand for LAL endotoxin testing

Kevin Williams from bioMerieux discusses the recombinant Factor C assay that has been developed to help alleviate the pressures of a growing demand for the Limulus amoebocyte lysate assay
Finance

bioMerieux acquires molecular testing company

The acquisition of the molecular testing platform, Veriflow, will compliment bioMérieux’s Gene-up system
Analysis

bioMérieux launches automated diagnostic solution for microbial detection

EviSight Compact provides reliable results for increased product safety and reduces costs for pharmaceutical companies
Finance

bioMérieux sees strong sales growth in first half of 2016

Expanded business portfolio and launch of new database and reagent kits boosts company momentum
Subscribe now